NBBK vs RARE · P/E 14, rev $335.7M vs rev $350.0M
NB Bancorp, Inc. Common Stock (NBBK) versus Ultragenyx (RARE) — a side-by-side from cached financials, not a winner call.
NB Bancorp, Inc. Common Stock (NBBK) is a banks - regional company listed on US.
Ultragenyx (RARE) is a biotechnology company listed on US.
Latest reported NBBK revenue for 2025-12-31 was $335.7M. Net income was $50.3M. Revenue was up 14.8% from 2024-12-31 to 2025-12-31. NBBK currently screens at market cap $863.3M and trailing P/E 14.4.
Latest reported RARE revenue for 2026-06-30 was $350.0M. Net income was -$277.0M. RARE currently screens at market cap $2.79B.
NBBK currently screens at market cap $863.3M and trailing P/E 14.4. RARE currently screens at market cap $2.79B.
Not investment advice. Open the NBBK and RARE stock pages for the full models.
Not investment advice.